Articles with public access mandates - Keaven M AndersonLearn more
Not available anywhere: 2
Transition-metal-free one-pot tandem synthesis of 4-quinolone and 4H-thiochromen-4-one derivatives through sequential nucleophilic addition–elimination–SNAr reaction
D Wang, P Sun, P Jia, J Peng, Y Yue, C Chen
Synthesis 49 (18), 4309-4320, 2017
Mandates: National Natural Science Foundation of China
Palladium-Catalyzed Cross-Coupling Reactions of 4-Tosyloxyquinazolines with Indoles: An Efficient Approach to 4-(1H-Indol-1-yl) quinazolines
X Ye, J Huang, Z Deng, J Yuan, Y Peng
Synthesis 53 (02), 383-390, 2021
Mandates: National Natural Science Foundation of China
Available somewhere: 9
Baseline tumor size is an independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab
RW Joseph, J Elassaiss-Schaap, R Kefford, WJ Hwu, JD Wolchok, ...
Clinical Cancer Research 24 (20), 4960-4967, 2018
Mandates: US National Institutes of Health
Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies
Collaborative Group on Epidemiological Studies of Ovarian Cancer
The Lancet Oncology 13 (9), 946-956, 2012
Mandates: US National Institutes of Health, Cancer Research UK
On the empirical choice of the time window for restricted mean survival time
L Tian, H Jin, H Uno, Y Lu, B Huang, KM Anderson, LJ Wei
Biometrics 76 (4), 1157-1166, 2020
Mandates: US National Science Foundation, US National Institutes of Health
New high-sensitivity searches for neutrons converting into antineutrons and/or sterile neutrons at the HIBEAM/NNBAR experiment at the European Spallation Source
A Addazi, K Anderson, S Ansell, KS Babu, JL Barrow, DV Baxter, ...
Journal of Physics G: Nuclear and Particle Physics 48 (7), 070501, 2021
Mandates: US National Science Foundation, US Department of Energy, Swedish Research …
Log-rank test vs MaxCombo and difference in restricted mean survival time tests for comparing survival under nonproportional hazards in immuno-oncology trials: a systematic …
P Mukhopadhyay, J Ye, KM Anderson, S Roychoudhury, EH Rubin, ...
JAMA oncology 8 (9), 1294-1300, 2022
Mandates: US National Institutes of Health
340O Radiotherapy is associated with deletion signatures that contribute to poor survival outcomes in cancer patients
E Kocakavuk, K Anderson, F Varn, K Johnson, S Amin, F Barthel, ...
Annals of Oncology 32, S516, 2021
Mandates: US National Institutes of Health
Is waveform worth it? A comparison of LiDAR approaches for vegetation and landscape characterisation
MI Disney, K Anderson, S Hancock, KJ Gaston
Remote Sensing in Ecology and Conservation 2 (1), 5-15, 2016
Mandates: UK Natural Environment Research Council
University of Pennsylvania 6th annual conference on statistical issues in clinical trials: Dynamic treatment regimes (morning session)
K Anderson, M Joffe, MR Kosorok
Clinical Trials 11 (4), 418-425, 2014
Mandates: US National Institutes of Health
Pain and survival in patients with squamous cell cancer of the head and neck (HNSCC): analysis of 2,622 newly diagnosed HNSCC patients
C Reyes-Gibby, S Shete, K Merriman, K Anderson, K Todd, E Hanna
The Journal of Pain 14 (4), S12, 2013
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program